Pfizer drops India vaccine application after regulator seeks local trial; they did not want a trial there? why Pfizer? you want approval based on what? prior trial? India said NO, eff off
China still does not use mRNA vaccines on anyone so what does China know too? what do you think? not on their police, not on their soldiers but US, Canada, UK etc. jabbed theirs...how come?
Update: colleague reminded me this is in 2021 so not this week, but all the same the story is what is critical…especially as to China…the question is why?
Pfizer drops India vaccine application after regulator seeks local trial | Reuters
Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study.
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future. Both countries are running their immunisation campaigns using other products.
Unlike other companies conducting small studies in India for foreign-developed vaccines, Pfizer had sought an exception citing approvals it had received elsewhere based on trials done in countries such as the United States and Germany.
Indian health officials say they generally ask for so-called bridging trials to determine if a vaccine is safe and generates an immune response in its citizens. There are, however, provisions under India’s rules to waive such trials in certain conditions.
The U.S. company, which was the first drugmaker to seek emergency approval in India for its vaccine developed with Germany’s BioNTech, made the withdrawal decision after a meeting with India’s Central Drugs Standard Control Organisation (CDSCO) on Wednesday.
Can every other country on earth do that and end this mass murder spree??
There is no current emergency, these products should not be granted Emergency Use Authorization in new markets and the EUA in existing markets should be revoked or ended.